Thirty-five patients with menorrhagia and a normal uterine cavity underwent hysteroscopic endomyometrial resection. None underwent any form of medical or surgical preparation of the endometrium. A standard gynecologic resectoscope was used to excise a minimum of 3 mm of endomyometrium from the entire uterine cavity. This depth was reduced to 2 mm at the tubal ostia. All patients were followed for 3-6 months. Twenty-one of the 25 patients (84%) who were followed at 6 months reported amenorrhea. The mean dysmenorrhea scores improved from 2.84 to 0.56 postoperatively. Seven of the 35 patients were diagnosed with adenomyosis. One woman was found to have adenomatous hyperplasia of the endometrium. Hysteroscopic endomyometrial resection is a highly effective method for the treatment of menorrhagia. This technique produces a very high rate of amenorrhea, provides a histologic specimen of the endomyometrium, and obviates the need for medical or surgical preparation of the endometrium.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Resectoscopic Surgery Part III: Advanced Resectoscopic Surgery.
Surg Technol Int
May 2022
Center for Menstrual Disorders, Clinical Associate Professor of Gynecology, University of Rochester Medical Center, Rochester, New York.
In this final section of our three-part series, we will apply the basic and intermediate skills described in the first two parts to advance the gynecologist's skills to accomplish the most demanding of resectoscopic surgical challenges. In Part I of this series, we reviewed the benefits of the continuous flow gynecologic resectoscope (CFGR) and how the motivated gynecologist can assemble an operative team and overcome the impediments to learning the use of this versatile and minimally invasive instrument. In this first section, we outlined and analyzed basic resectoscopic surgery-endometrial ablation, the resection of small submucous myomas and endometrial polyps, as well as the treatment of mild Asherman's syndrome and the removal of retained products of conception.
View Article and Find Full Text PDFResectoscopic Surgery Part II: Introducing Ultrasound Guidance for Intermediate-Level Surgical Procedures.
Surg Technol Int
September 2021
Clinical Associate Professor of Gynecology, Center for Menstrual Disorders, University of Rochester Medical Center, Rochester, New York.
In Part I of this three-part series, the author reviewed the importance of resectoscopic surgery and the many advantages it provides to the patient and to the minimally invasive gynecologic surgeon. In Part I, we reviewed the obstacles to mastering this 30-year-old technology and how the motivated surgeon can overcome them. Although many basic resectoscopic procedures have been supplanted by global endometrial ablation (GEA) devices and hysteroscopic morcellators (HMs), the limitations of these restrictive technologies are quickly evident as the surgeon encounters increasingly complex and demanding cases.
View Article and Find Full Text PDFResectoscopic Surgery Part I: Overcoming Obstacles and Mastering the Basics.
Surg Technol Int
May 2021
Clinical Associate Professor of Gynecology, University of Rochester Medical Center, Rochester, New York.
The introduction of the continuous flow gynecologic resectoscope (CFGR) in 1989 revolutionized minimally invasive gynecologic surgery (MIGS) by introducing such intrauterine procedures as hysteroscopic myomectomy, polypectomy, and endometrial ablation. However, with the subsequent introduction of global endometrial ablation (GEA) devices and hysteroscopic morcellators (HMs), the CFGR has fallen into relative disuse-a regrettable situation since it remains ideally suited for accomplishing many procedures that are otherwise not achievable with these newer technologies. Procedures which involve greater precision and control-endomyometrial resection (EMR), hysteroscopic metroplasty, the correction of isthmoceles, the resection of intramural myomas, and the management of late-onset endometrial ablation failure-are only possible with the CFGR.
View Article and Find Full Text PDFManagement of a Thin Endometrium by Hysteroscopic Instillation of Platelet-Rich Plasma Into The Endomyometrial Junction: A Pilot Study.
J Clin Med
August 2020
Department of Obstetrics and Gynecology, Arnold-Heller-Str. 3, House C, University Hospitals Schleswig-Holstein, 24105 Kiel, Germany.
In patients whose embryo transfer has been previously canceled due to a thin endometrium, the injection of platelet-rich plasma (PRP) guided by hysteroscopy into the endomyometrial junction improves endometrial thickness and vascularity. This may well serve as a novel approach for the management of these patients. In this study, 32 patients aged between 27 and 39 years, suffering from primary or secondary infertility, were selected for hysteroscopic instillation of PRP.
View Article and Find Full Text PDFConservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study.
J Gynecol Oncol
July 2019
Department of Obstetrics, Gynecology and Reproductive Biology, DIMEC, S.Orsola Hospital, University Alma Mater Studiorum of Bologna, Bologna, Italy.
Objective: To report hysteroscopic treatment combined with levonorgestrel-releasing intrauterine device (LNG-IUD) to treat women with early well differentiated endometrial cancer (EC) at high surgical risk.
Methods: Nine women diagnosed with stage IA, grade 1 endometrioid EC which was contraindicated or refused standard treatment with external beam radiation therapy with or without brachytherapy were enrolled in our prospective study. Endo-myometrial hysteroscopic resection of the whole uterine cavity and the placement of LNG-IUD for 5 years was performed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!